N-Nitroso Ciprofloxacin EP Impurity C
N-Nitroso Ciprofloxacin EP Impurity C is listed under Nitrosamine and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Ciprofloxacin. The product is supplied by Clearsynth under CAT No. CS-O-46370. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Product Specifications
Overview
Useful research chemical for a range of applications.
Synonyms
N-Nitroso Ciprofloxacin EP Impurity C
Molecular Formula
C 15 H 15 FN 4 O 4
Molecular Weight
334.3
Additionnal Information
N-Nitroso Ciprofloxacin EP Impurity C is supplied with detailed characterization data compliant with regulatory guideline. N-Nitroso Ciprofloxacin EP Impurity C can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Ciprofloxacin.
Storage Conditions
Refer MSDS for complete information.
Applications Notes
Useful research chemical for a range of applications.
HSN Code
38229010
Hazard Compound
Refer MSDS for complete information.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2061235-01 0.1 mL
FITC-Linked Monoclonal Antibody to Apolipoprotein A4 (APOA4)
Sign In for Pricing
View Details MBS2061235-02 0.2 mL
FITC-Linked Monoclonal Antibody to Apolipoprotein A4 (APOA4)
Sign In for Pricing
View Details MBS2061235-03 0.5 mL
FITC-Linked Monoclonal Antibody to Apolipoprotein A4 (APOA4)
Sign In for Pricing
View Details MBS2061235-04 1 mL
FITC-Linked Monoclonal Antibody to Apolipoprotein A4 (APOA4)
Sign In for Pricing
View Details MBS2061235-05 5 mL
FITC-Linked Monoclonal Antibody to Apolipoprotein A4 (APOA4)
Sign In for Pricing
View Details MBS2061235-06 5x 5 mL
FITC-Linked Monoclonal Antibody to Apolipoprotein A4 (APOA4)
Sign In for Pricing
View Details